Chiba, Japan

Osamu Yokosuka

This inventor holds 1 USPTO granted patent. Top assignee: Chiba University. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Osamu Yokosuka. Retrieved from https://idiyas.com/inventor/osamu-yokosuka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Osamu Yokosuka: Innovator in Biliary Tract Cancer Detection

Introduction

Osamu Yokosuka is a prominent inventor based in Chiba, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of biliary tract cancer. His innovative approach has the potential to improve early detection and treatment outcomes for patients.

Latest Patents

Yokosuka holds a patent for a method of detecting an abnormal amount of a biomarker associated with biliary tract cancer. This method involves quantitating a fragment of prothrombin with an m/z value of about 4204 in a biological sample. The quantitated value is then compared with a threshold value to determine the presence of the cancer biomarker. This patent represents a significant advancement in cancer diagnostics.

Career Highlights

Osamu Yokosuka is affiliated with Chiba University, where he conducts research and develops innovative medical technologies. His work has garnered attention for its potential impact on cancer detection and patient care.

Collaborations

Yokosuka has collaborated with notable colleagues, including Shintaro Kikkawa and Kazuyuki Sogawa. These partnerships have contributed to the advancement of research in the field of biliary tract cancer.

Conclusion

Osamu Yokosuka's contributions to the detection of biliary tract cancer through innovative methods highlight his role as a key inventor in the medical field. His work continues to pave the way for advancements in cancer diagnostics and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…